The pgsBCA-gene disruptant from Bacillus subtilis ISW1214, i.e., MA41, does not produce poly--glutamate (PGA). We newly constructed an MA41 recombinant bearing the plasmid-borne PGA synthetic system, in which PGA production was strictly controlled by the use of xylose. Unlike the parent strain, ISW1214, the genetically engineered strain produced abundant PGA in both L-glutamate-rich and D-glutamate-rich media.
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Poly--glutamate (PGA) is the most promising biopolymer in industry, the environment, and pharmaceuticals.
1) It has been assumed that Bacillus licheniformis produces poly--D-glutamate (D-PGA) from L-glutamate alone in a thiotemplate-dependent multi-enzymelike fashion, 2) which involves a unidirectional isomerization process 3) of L-to D-glutamyl residues in a PGA chain. In contrast, the extracellular polymer from Bacillus subtilis is actually a mixture of multi-anionic copolymers in which D-and L-glutamyl residues are randomly aligned, 1) as in the case of poly--DL-glutamate (DL-PGA). Although two distinct mechanisms for the biosynthesis of DL-PGA have been proposed, 1) it was difficult to assess whether, in the polymer production by B. subtilis cells, it is formed from L-glutamate alone, 4, 5) as does B. licheniformis, or whether D-glutamate also serves as a substrate 6) according to an amide ligase 7, 8) -like manner. 9, 10) Intricate regulation of PGA production in B. subtilis 11, 12) causes a difficulty in the interpretation of this issue. In this study, to simplify the regulation of PGA production and construct a more convenient PGA producer, genetic alterations were preformed to B. subtilis ISW1214, which is a tetracycline-susceptible derivative from the 1012 strain of B. subtilis R 13, 14) and also the leucine/methionine auxotroph. 13) Similarly to B. subtilis 168, 11) B. subtilis ISW1214 is a domestic strain very useful in gene engineering, 13) which harbors no plasmid DNA. 14) It, however, has remained obscure about whether the ISW1214 strain cannot produce PGA as well as the 168 strain.
11) Then we examined the polymer productivity of B. subtilis ISW1214. Growing cells (wet weight, 0.4 g) of B. subtilis ISW1214 were first inoculated into the following three media (50 ml): a standard (S) medium consisting of 5% sucrose, 0.5% MgSO 4 . 7H 2 O, 0.27% KH 2 PO 4 , 0.42% Na 2 HPO 4 , 0.05% NaCl, a Murashige-Skoog vitamin solution (PhytoTechnology Laboratories, Shawnee Mission, KS.), and two essential amino acids (Lleucine and L-methionine, each 0.5 mg ml À1 ); and the LS and DS media, in which excess L-and D-glutamate (50 mg ml À1 , viz., 340 mM) were further added to the S medium, respectively. Cells were incubated in each medium for 5 d at 30
C and centrifuged at 12;000 Â g for 30 min at 4 C. PGA was prepared from the supernatant according to the usual procedures 1) and purified by anion-exchange chromatography. 15) Purified PGA was determined by the method described previously. 15) B. subtilis ISW1214 produced a large amount of PGA in the LS medium (about 4.4 mg ml À1 ) and only a slight amount of PGA in the DS medium (about 0.3 mg ml À1 ), but did not produce PGA in the S medium with no glutamate. PGA productivity of ISW1214, however, was not observed in the presence of a lower concentration of L-glutamate (e.g., 2, 3, or 5 mM). 4) B. subtilis ISW1214 is thus similar to naturally occurring PGA over-producers of B. subtilis, such as B. subtilis (natto) and B. subtilis subsp. chungkookjang, 1) in the requirement of a high concentration of L-glutamate for PGA production.
Recent research indicates that the pgsBCA genes encode the sole machinery for PGA synthesis in B. subtilis, 9, 16) viz., the PGA synthetase complex, in which the PgsB component shows structural features seen commonly in the amide ligase family 6) but the other two components (PgsC and PgsA) 16) do not encompass y To whom correspondence should be addressed. Fax: +81-888-64-5200; E-mail: ashiuchi@cc.kochi-u.ac.jp Abbreviations: PGA, poly--glutamate; Cm, chloramphenicol; LA-PCR, long amplification-polymerase chain reaction; Tc, tetracycline; SDS-PAGE, SDS-polyacrylamide gel electrophoresis any structural motifs that involve thiotemplate-dependent biopolymer syntheses. 3, 17) In fact, a naturally occurring PGA over-producer, B. subtilis subsp. chungkookjang, completely lost the polymer productivity due to the pgsBCA-gene disruption, 9) and the constructed mutant was named MA11. To ascertain the similarity between B. subtilis ISW1214 and B. subtilis subsp. chungkookjang in PGA production, we constructed the pgsBCAgene disruptant of B. subtilis ISW1214 as follows: First, the pKPSd plasmid 9) carrying the chloramphenicol (Cm)-resistance gene, which is useful for pgsBCA-gene disruption of various B. subtilis strains, was applied. Then chromosomal alteration was verified by a genetic strategy involving the amplification of the target region by LA-PCR and the sequencing of the DNA fragment using the PPGS-U (5 0 -TCATAGTGATTCTATATACT-GATGAAT-3 0 ) and PPGS-D (5 0 -TTTGAATATGTTA-AGAGACTTTTTAAT-3 0 ) primers, as described previously.
9) The pgsBCA-gene disruptant obtained was named MA41. It acquired Cm-resistance but lost PGA productivity. The phenotype of the MA41 mutant was thus consistent with that of the MA11 mutant of B. subtilis subsp. chungkookjang.
9)
It appears likely that the pgsB, -C, and -A genes are at least indispensable for transformation of E. coli into a PGA producer, 1, 16, 18) but a recent study of PGA production by B. subtilis cells suggests that both the ywsC (corresponding to pgsB) and ywtA (pgsC) gene products are indeed essential, but that the ywtB (pgsA) gene product is dispensable. 18) We expected that a genetic complementation test of MA41 about PGA productivity would give a clue to this puzzle. Vectors to control pgs-gene expression were constructed as follows: First, DNA fragments containing the pgsB, -C, and -A genes of B. subtilis ISW1214 were amplified by the PCR method with the PPGSB-NF2 and PPGSB-CR primers, the PPGSC-NF and PPGSC-CR primers, and the PPGSA-NF and PPGSA-CR2 primers, 9) respectively. The pgsB, -C, and -A gene-containing fragments were verified with an automatic DNA sequencer, and then introduced into the multi-cloning site of Bacillus expression vector pWH1520 carrying the tetracycline (Tc)-resistance gene (MoBiTec, Göttingen, Germany). Figure 1 shows the structures of eight pgs vectors thus developed: pWPGB1, pWPGC1, pWPGA1, pWPGBC1, pWPGBA1, pWPGCA1, pWPGS1, and pWPGO1. The MA41 mutant was transformed with these pgs vectors by the competence method. 6) Recombinants were screened on a plate of Luria-Bertani medium 19) with appropriate antibiotics (e.g., Tc, 10 mg ml À1 ; Cm, 5 mg ml À1 ). The recombinant harboring the pWPGS1 vector was tentatively abbreviated to MA41/pWPGS1, and other recombinants constructed were also named in the same way. For pgs-gene induction, we newly prepared a modified (X) medium, in which D-xylose (5%) and L-arabinose (1%) that activates the xylose uptake of B. subtilis cells 20) were substituted for sucrose of the S medium. Excess L-and D-glutamate were added to the X medium, and named the LX and DX media, respectively. PGA productivities of these pgs recombinants were then examined, and we found that only the MA41/ pWPGS1 and MA41/pWPGO1 recombinants, which are complemented by all the pgsB, -C, and -A genes, produced high-molecular-mass PGA in the presence of D-xylose and L-arabinose (Fig. 2 top, lanes 7 and 8) . In contrast, the MA41/pWPGBC1 recombinant (lacking the pgsA gene) did not produce the extracellular polymer (lane 4). These results indicate that all the pgsB, -C, and -A gene products are indispensable for B. subtilis PGA production, at least in the use of the plasmid-borne PGA synthetic system. In addition, the genetically engineered PGA producers never produce the polymer in the absence of D-xylose and L-arabinose (Fig. 2, bottom) . Development of the plasmid-borne PGA synthetic system for B. subtilis thus allowed a strict control in the initiation of the polymer production. We further observed that the genetically engineered strains, MA41/ pWPGS1 and MA41/pWPGO1, produced abundant PGA even in the DX medium (data not shown), unlike the parent strain ISW1214. In fact, the former and latter strains accumulated PGA at about 8.2 and 3.8 mg ml medium, respectively. Accordingly, the polymer productivity of MA41/pWPGS1 is usually higher than that of MA41/pWPGO1. This benefit is probably brought by a simple modification in the gene structure, namely that the typical ribosome-binding sequence is designed at the immediate upstream of each pgs gene on the pWPGS1 vector so as to increase the translation levels of the pgsC and -A genes besides that of the pgsB gene (Fig. 1) . Nevertheless, neither engineered strain produced PGA in the presence of a lower concentration of glutamate (e.g., 5 mM).
4) The result indicates that excess glutamate is required as the polymer substrate in B. subtilis.
To our knowledge, this is the first example of effective PGA production in the presence of D-glutamate. It appears likely that the genetic strategy constructed in this study not only serves to deepen understanding of PGA biosynthesis, but also is applicable in mass-production of the useful biopolymer, because naturally occurring PGA producers, e.g., B. subtilis (natto), often make L-glutamate-rich media highly viscous half-way through the process of cultivation due to the extreme accumulation of PGA. , and MA41/pWH1520 (the negative control, lane 9), which were prepared after incubation for 5 d at 30 C in the LX medium (top) and the LS medium (bottom). Tetracycline (10 mg ml À1 ) was essentially added to the media for the PGA-production test (5 d of incubation at 30 C).
